05 Feb 2026
18:02 CET |
EQUASENS |
Solides performances commerciales en 2025 : revenu annuel récurrent (ARR) de 108,0 M€ (+8,8% en publié au 31/12/25) et chiffre d’affaires annuel de 236,5 M€ (+9,1% en publié)
|
20101025 Health Services |
Sales |
05 Feb 2026
18:02 CET |
EQUASENS |
Strong commercial performance in 2025: Annual Recurring Revenue (ARR) of €108.0m (+8.8% as reported on 31 December 2025) and full-year revenue of €236.5m (+9.1% as reported)
|
20101025 Health Services |
Sales |
07 Jan 2026
19:02 CET |
EQUASENS |
BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT
|
20101025 Health Services |
Other subject |
05 Jan 2026
08:00 CET |
EQUASENS |
EQUASENS ACCELERE DANS LA FORMATION DIGITALE DEDIEE AUX PROFESSIONNELS DE SANTE AVEC L’ACQUISITION D’EREVO, LEADER « PURE PLAYER » DU E-LEARNING
|
20101025 Health Services |
Mergers, Acquisitions, Transfers |
05 Jan 2026
08:00 CET |
EQUASENS |
EQUASENS ACCELERATES ITS DIGITAL TRAINING STRATEGY FOR HEALTHCARE PROFESSIONALS WITH THE ACQUISITION OF EREVO, A LEADING PURE-PLAY E-LEARNING PROVIDER
|
20101025 Health Services |
Mergers, Acquisitions, Transfers |
10 Dec 2025
18:00 CET |
EQUASENS |
EQUASENS ANNONCE SON AGENDA FINANCIER 2026
|
20101025 Health Services |
Corporate life |
10 Dec 2025
18:00 CET |
EQUASENS |
EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR
|
20101025 Health Services |
Corporate life |
05 Nov 2025
18:00 CET |
EQUASENS |
EQUASENS : Chiffre d'affaires au 30 septembre 2025
|
20101025 Health Services |
Sales |
05 Nov 2025
18:00 CET |
EQUASENS |
Equasens: Q3 2025 revenue
|
20101025 Health Services |
Sales |
30 Sep 2025
18:04 CEST |
EQUASENS |
EQUASENS : Mise à disposition du rapport financier semestriel 2025
|
20101025 Health Services |
Income |
29 Sep 2025
08:00 CEST |
EQUASENS |
EQUASENS : Bilan S1 2025 contrat de liquidité
|
20101025 Health Services |
Other subject |
26 Sep 2025
18:00 CEST |
EQUASENS |
EQUASENS : Résultats semestriels 2025
|
20101025 Health Services |
Income |
26 Sep 2025
18:00 CEST |
EQUASENS |
Equasens: 2025 half-year results
|
20101025 Health Services |
Income |
31 Jul 2025
18:00 CEST |
EQUASENS |
EQUASENS : Chiffre d’affaires au 30 juin 2025 à 116,0 M€
|
10101015 Software |
Sales |
31 Jul 2025
18:00 CEST |
EQUASENS |
Equasens: H1 revenue at 30 June 2025: €116.0m
|
10101015 Software |
Sales |
03 Jul 2025
18:00 CEST |
EQUASENS |
Equasens: Appointment at the head of the Pharmagest Division
|
10101015 Software |
Journal / appointments |
03 Jul 2025
18:00 CEST |
EQUASENS |
EQUASENS : Nomination à la direction de la Division Pharmagest
|
10101015 Software |
Journal / appointments |
01 Jul 2025
19:00 CEST |
EQUASENS |
EQUASENS : Assemblée Générale - Résultats des votes
|
10101015 Software |
General meeting / Board Meeting |
01 Jul 2025
19:00 CEST |
EQUASENS |
Equasens: General meeting - Results of the votes
|
10101015 Software |
General meeting / Board Meeting |
30 Jun 2025
18:00 CEST |
EQUASENS |
EQUASENS : ACQUISITION DES ACTIVITES DIS ET RESURGENCES
|
10101015 Software |
Mergers, Acquisitions, Transfers |
30 Jun 2025
18:00 CEST |
EQUASENS |
Equasens: acquisition of DIS and RESURGENCES BUSINESSES
|
10101015 Software |
Mergers, Acquisitions, Transfers |
06 Jun 2025
18:00 CEST |
EQUASENS |
EQUASENS : modalités de mise à disposition des documents préparatoires à l'AG
|
10101015 Software |
General meeting / Board Meeting |
06 Jun 2025
18:00 CEST |
EQUASENS |
Equasens: availability of AGM preparatory materials
|
10101015 Software |
General meeting / Board Meeting |
12 May 2025
18:00 CEST |
EQUASENS |
EQUASENS : Chiffre d’affaires au 31 mars 2025
|
10101015 Software |
Sales |
12 May 2025
18:00 CEST |
EQUASENS |
Equasens: Q1 revenue at 31 March 2025
|
10101015 Software |
Sales |
30 Apr 2025
16:00 CEST |
EQUASENS |
EQUASENS :
|
10101015 Software |
Income |
30 Apr 2025
08:00 CEST |
EQUASENS |
EQUASENS : ENTREE EN NEGOCIATION EXCLUSIVE AVEC UN EDITEUR DE SOLUTIONS LOGICIELLES FRANÇAIS
|
10101015 Software |
Mergers, Acquisitions, Transfers |
30 Apr 2025
08:00 CEST |
EQUASENS |
Equasens: EXCLUSIVE NEGOTIATIONS INITIATED WITH A FRENCH SOFTWARE EDITOR
|
10101015 Software |
Mergers, Acquisitions, Transfers |
28 Mar 2025
18:00 CET |
EQUASENS |
EQUASENS : Résultats annuels 2024
|
10101015 Software |
Income |
28 Mar 2025
18:00 CET |
EQUASENS |
Equasens: 2024 annual results
|
10101015 Software |
Income |
06 Feb 2025
18:00 CET |
EQUASENS |
Equasens: 2024 annual revenue
|
10101015 Software |
Sales |
06 Feb 2025
18:00 CET |
EQUASENS |
EQUASENS : Chiffre d’affaires au 31 décembre 2024
|
10101015 Software |
Sales |
08 Jan 2025
18:00 CET |
EQUASENS |
EQUASENS : bilan semestriel S2 2024 du contrat de liquidité contracté avec Gilbert Dupont
|
10101015 Software |
Share history |
27 Dec 2024
18:00 CET |
EQUASENS |
EQUASENS : acquisition stratégique de Calimed, expert en logiciel SaaS pour les médecins libéraux et les chirurgiens
|
10101015 Software |
Mergers, Acquisitions, Transfers |
27 Dec 2024
18:00 CET |
EQUASENS |
Equasens: strategic acquisition of Calimed, a SaaS software expert for private practitioners and surgeons
|
10101015 Software |
Mergers, Acquisitions, Transfers |
21 Nov 2024
18:00 CET |
EQUASENS |
EQUASENS : Digipharmacie obtient l’immatriculation officielle en tant que Plateforme de Dématérialisation Partenaire (PDP)
|
10101015 Software |
Corporate life |
20 Nov 2024
18:01 CET |
EQUASENS |
EQUASENS : Intelligence artificielle : Equasens et Posos transforment la dispensation pharmaceutique
|
10101015 Software |
Corporate life |
07 Nov 2024
18:00 CET |
EQUASENS |
EQUASENS : Chiffre d’affaires au 30 septembre 2024 à 158,2 M€ - Retour de la croissance sur le T3 (+0,3%)
|
10101015 Software |
Sales |
07 Nov 2024
18:00 CET |
EQUASENS |
Equasens: 2024 nine-month revenue: €158.2 million - Return to growth in Q3 (+0.3%)
|
10101015 Software |
Sales |
30 Sep 2024
20:04 CEST |
EQUASENS |
EQUASENS : Modalités de mise à disposition du rapport financier semestriel 2024
|
10101015 Software |
Income |
27 Sep 2024
18:00 CEST |
EQUASENS |
EQUASENS : Résultats semestriels 2024
|
10101015 Software |
Income |
27 Sep 2024
18:00 CEST |
EQUASENS |
Equasens: 2024 half-year results
|
10101015 Software |
Income |
02 Aug 2024
18:00 CEST |
EQUASENS |
EQUASENS : Chiffre d’affaires S1 2024
|
10101015 Software |
Sales |
02 Aug 2024
18:00 CEST |
EQUASENS |
Equasens: H1 2024 revenue
|
10101015 Software |
Sales |
05 Jul 2024
18:30 CEST |
EQUASENS |
EQUASENS : BILAN SEMESTRIEL S1-2024 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT
|
10101015 Software |
Share history |
05 Jul 2024
18:00 CEST |
EQUASENS |
EQUASENS : AGO du 27 juin 2024 - RESULTAT DU VOTE DES RESOLUTIONS
|
10101015 Software |
General meeting / Board Meeting |
05 Jul 2024
18:00 CEST |
EQUASENS |
Equasens: RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 27 JUNE 2024
|
10101015 Software |
General meeting / Board Meeting |
10 Jun 2024
18:00 CEST |
EQUASENS |
EQUASENS : ASSEMBLEE GENERALE ORDINAIRE ANNUELLE - AVIS DE CONVOCATION - MISE EN LIGNE DES DOCUMENTS PREPARATOIRES
|
10101015 Software |
General meeting / Board Meeting |
10 Jun 2024
18:00 CEST |
EQUASENS |
Equasens: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS
|
10101015 Software |
General meeting / Board Meeting |
07 May 2024
18:00 CEST |
EQUASENS |
Equasens: Q1 2024 revenue
|
10101015 Software |
Sales |